scholarly article | Q13442814 |
P50 | author | Luca Presotto | Q57077231 |
Alessandro Stefano | Q57078063 | ||
Rosa Maria Moresco | Q88784635 | ||
Nadia Zaffaroni | Q38591092 | ||
P2093 | author name string | Maria Grazia Daidone | |
Emilio Bombardieri | |||
Silvia Valtorta | |||
Isabella Raccagni | |||
Sara Belloli | |||
Giorgio Russo | |||
Monica Tortoreto | |||
Anna Bogni | |||
Claudio Pascali | |||
P2860 | cites work | Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. | Q53496753 |
Association of EGFR expression level and cetuximab activity in patient-derived xenograft models of human non-small cell lung cancer. | Q54343436 | ||
Simple preparation and purification of ethanol-free solutions of 3'-deoxy-3'-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges | Q82975908 | ||
Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings | Q83769974 | ||
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy | Q84806666 | ||
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells | Q38941727 | ||
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer | Q41624801 | ||
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. | Q44735837 | ||
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer | Q46676989 | ||
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Q46771645 | ||
Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods | Q46788429 | ||
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. | Q46872269 | ||
An enhanced random walk algorithm for delineation of head and neck cancers in PET studies. | Q48350228 | ||
Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer. | Q48444536 | ||
Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer | Q49017971 | ||
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study. | Q51009203 | ||
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model. | Q52991636 | ||
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer. | Q53061114 | ||
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel. | Q53194822 | ||
Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim | Q53261275 | ||
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice | Q28475583 | ||
[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts | Q28484852 | ||
Triple-Negative Breast Cancer | Q29391607 | ||
Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer. | Q33750115 | ||
Triple-negative breast cancer | Q34274939 | ||
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype? | Q34476337 | ||
Histological, molecular and functional subtypes of breast cancers | Q34616569 | ||
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice | Q34645445 | ||
Triple-negative breast cancer: new perspectives for targeted therapies. | Q35001758 | ||
Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET | Q35081130 | ||
18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in mice | Q35120054 | ||
Choosing the right cell line for breast cancer research | Q35608671 | ||
How can grafted breast cancer models be optimized? | Q35760911 | ||
[18F]FLT-PET in oncology: current status and opportunities | Q35964138 | ||
Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer | Q36495792 | ||
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688 | Q36533964 | ||
18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer | Q36557319 | ||
Molecular imaging as a tool for translating breast cancer science | Q37019264 | ||
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging | Q37522770 | ||
Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer. | Q37580294 | ||
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients | Q37705395 | ||
Molecular imaging for monitoring treatment response in breast cancer patients. | Q38094852 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0197754 | |
P577 | publication date | 2018-05-23 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer | |
P478 | volume | 13 |